Skip to main content
Signal8

Bhatt Nailesh

SEC insider (Form 3/4/5 filer). CIK 0001806525. Director at Hyperliquid Strategies Inc (PURR) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in NEW YORK, NY.

Companies Bhatt Nailesh has filed insider reports for

  • Hyperliquid Strategies Inc (PURR): Director
  • Sonnet BioTherapeutics Holdings, Inc. (SONN): Director
Bhatt Nailesh profile photo

Bhatt Nailesh

CIK: 0001806525

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Hyperliquid Strategies Inc logo
PURR

Hyperliquid Strategies Inc

Director
Sonnet BioTherapeutics Holdings, Inc. logo
SONN

Sonnet BioTherapeutics Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Hyperliquid Strategies Inc logo
    PURR

    Hyperliquid Strategies Inc

    Oct 1, 2026
    Award
    Direct
    2K shares-
  • Hyperliquid Strategies Inc logo
    PURR

    Hyperliquid Strategies Inc

    Jul 1, 2026
    Award
    Direct
    1.6K shares-
  • Hyperliquid Strategies Inc logo
    PURR

    Hyperliquid Strategies Inc

    Apr 1, 2026
    Award
    Direct
    2.5K shares-
  • Hyperliquid Strategies Inc logo
    PURR

    Hyperliquid Strategies Inc

    Feb 9, 2026
    Award
    Direct
    40.8K shares-
  • Hyperliquid Strategies Inc logo
    PURR

    Hyperliquid Strategies Inc

    Dec 2, 2025
    Other
    Direct
    2.1K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Disposition
    Direct
    10.5K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Jul 11, 2025
    Award
    Direct
    10K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 11, 2023
    Award
    Direct
    373 shares-

1-8 of 8